A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

NCT05334706 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
Human Papillomavirus (HPV) Infections
High-risk HPV
HPV-16/ 18

Interventions

BIOLOGICAL: Nonavalent HPV vaccine (9vHPV/Gardasil-9™).

Sponsor

Miquel Angel Pavon Ribas

Collaborators

[object Object]
[object Object]